Steven Todd Kirsch is an American serial entrepreneur. He has started several companies, including Mouse Systems, Frame Technology Corp., Infoseek and OneID. He was one of two people who coincidentally invented the optical mouse. In 2007, his personal fortune was estimated at $230 million, the majority earned from the IPO of Infoseek and the acquisition of Frame Technology.
Steve although originally sceptical about the vaccine being dangerous has since become one of the most important soldiers in the front line trying to get the safety message out. He has put $1,000,000 of his own money into COVID-19 research, which has resulted in the use of Fluvoxamine as an effective part of COVID-19 treatment along with the early intervention protocols developed by the team of Front Line Covid Critical Care.
In this interview Riccardo lets Steve lose to share his vast knowledge on all things COVID-19.